• Explore /
  • Poster
  • / CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).

CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).

Abstract Poster

Authors

null

Ryan JO Dowling

Princess Margaret Cancer Centre, Toronto, ON, Canada

Ryan JO Dowling , Wendy R. Parulekar , Karen A. Gelmon , Lois E. Shepherd , Shakeel Virk , Marguerite Ennis , Fangya Mao , Jennifer A. Ligibel , Dawn L. Hershman , Priya Rastogi , Ingrid A. Mayer , Timothy J. Hobday , Julie Lemieux , Alastair Mark Thompson , Manuela Rabaglio-Poretti , Timothy Joseph Whelan , Vuk Stambolic , Bingshu E. Chen , Pamela Jean Goodwin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Local-Regional Therapy

Clinical Trial Registration Number

NCT01101438

Citation

J Clin Oncol 36, 2018 (suppl; abstr 557)

DOI

10.1200/JCO.2018.36.15_suppl.557

Abstract #

557

Poster Bd #

49

Abstract Disclosures

Similar Posters

First Author: Dawn L. Hershman

First Author: Pamela Jean Goodwin

First Author: Erin Frances Cobain

First Author: Marcela Carausu